Genomic Health Inc
(GHDX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Sales | 58,467 | 53,397 | 52,058 | 50,846 | 49,810 |
| Cost of Goods | 9,326 | 7,352 | 9,195 | 8,226 | 9,059 |
| Gross Profit | 49,141 | 46,045 | 42,863 | 42,620 | 40,751 |
| Operating Expenses | 48,596 | 43,665 | 39,659 | 40,486 | 41,042 |
| Operating Income | 871 | 2,732 | 3,399 | 2,360 | -232 |
| Interest Expense | 72 | 127 | 0 | 28 | 50 |
| Other Income | 74 | 117 | -36 | 75 | 65 |
| Pre-tax Income | 873 | 2,722 | 3,363 | 2,407 | -217 |
| Income Tax | 96 | 163 | 138 | 59 | 69 |
| Net Income Continuous | 777 | 2,559 | 3,225 | 2,348 | -286 |
| Net Income | $777 | $2,559 | $3,225 | $2,348 | $-286 |
| EPS Basic Total Ops | 0.03 | 0.09 | 0.11 | 0.08 | -0.01 |
| EPS Basic Continuous Ops | 0.03 | 0.09 | 0.11 | 0.08 | -0.01 |
| EPS Diluted Total Ops | 0.02 | 0.09 | 0.10 | 0.08 | -0.01 |
| EPS Diluted Continuous Ops | 0.02 | 0.08 | 0.10 | 0.08 | -0.01 |
| EBITDA(a) | $2,406 | $4,536 | $5,198 | $4,174 | $1,661 |